Dermatological Disorders

Perrigo Launches Generic Duac Gel

Perrigo announced that it has received final FDA approval for its abbreviated new drug application (ANDA) for clindamycin phosphate and benzoyl peroxide 1.2%/5% topical gel, the generic equivalent of Steifel Laboratories’ Duac Gel.